Correlation Between ATyr Pharma and Theseus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Theseus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Theseus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Theseus Pharmaceuticals, you can compare the effects of market volatilities on ATyr Pharma and Theseus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Theseus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Theseus Pharmaceuticals.
Diversification Opportunities for ATyr Pharma and Theseus Pharmaceuticals
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ATyr and Theseus is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Theseus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theseus Pharmaceuticals and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Theseus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theseus Pharmaceuticals has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Theseus Pharmaceuticals go up and down completely randomly.
Pair Corralation between ATyr Pharma and Theseus Pharmaceuticals
Given the investment horizon of 90 days ATyr Pharma is expected to under-perform the Theseus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, ATyr Pharma is 1.42 times less risky than Theseus Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Theseus Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 566.00 in Theseus Pharmaceuticals on August 30, 2024 and sell it today you would lose (195.00) from holding Theseus Pharmaceuticals or give up 34.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 41.11% |
| Values | Daily Returns |
ATyr Pharma vs. Theseus Pharmaceuticals
Performance |
| Timeline |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Theseus Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ATyr Pharma and Theseus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATyr Pharma and Theseus Pharmaceuticals
The main advantage of trading using opposite ATyr Pharma and Theseus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Theseus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theseus Pharmaceuticals will offset losses from the drop in Theseus Pharmaceuticals' long position.| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
| Theseus Pharmaceuticals vs. Relay Therapeutics | Theseus Pharmaceuticals vs. Century Therapeutics | Theseus Pharmaceuticals vs. Blueprint Medicines Corp | Theseus Pharmaceuticals vs. Pmv Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |